Skip to content

US · TNON · MEDICAL - DEVICES

Tenon Medical, Inc. (TNON) intrinsic value and stock valuation

$0.90as of 2026-11-21 · Mkt cap 967.54K

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Tenon Medical, Inc. DCF and intrinsic value

InvestorsCraft values TNON with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from TNON’s statements →

Tenon Medical, Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Devices Los Gatos, CA 95032 tenonmed.com

How the business is doing

Fiscal 2019–2025, USD

Revenue
$3.94M+150.4% 5y CAGRd
20192025
Net income
-$-12.56M
20192025
Free cash flow
-$-11.02M
20192025
Total equity
$5.04M
20192025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2019–2025, USD
20252024202320222021
Revenue$3.94M$3.28M$2.93M$690K$160K
Operating income-$-12.79M-$-13.77M-$-15.73M-$-18.73M-$-6.46M
Net income-$-12.56M-$-13.67M-$-15.58M-$-18.92M-$-7.05M
EPSd-$-1.7M-$-11.3M-$-67.74M-$-189.2M-$-705M
Operating cash flow-$-10.74M-$-9.88M-$-12.18M-$-12.03M-$-4.29M
Capital expenditure-$-270K-$-190K-$-360K-$-850K-$-100K
Free cash flow-$-11.02M-$-10.06M-$-12.54M-$-12.87M-$-4.39M
Total assets$10.8M$9.84M$6.34M$11.1M$9.27M
Total debt$140K$430K$1.86M$910K$14.6M
Net debt-$-3.62M-$-6.11M-$-570K-$-1.22M$11.7M
Total equity$5.04M$5.97M$780K$6.25M-$-20.55M
Cash and short-term investments$3.76M$6.54M$2.43M$8.57M$7.32M
Income statement
20252024202320222021
Revenue$3.94M$3.28M$2.93M$690K$160K
Cost of revenue$1.59M$1.57M$1.69M$1.33M$60K
Gross profit$2.36M$1.71M$1.24M-$-640K$100K
Research and development expenses$2.15M$2.6M$3.16M$2.83M$1.72M
Selling, general and administrative expenses$13M$12.9M$13.8M$15.3M$4.85M
Other expenses$0.00$0.00$0.00$0.00$0.00
Operating expenses$15.2M$15.5M$17M$18.1M$6.57M
Cost and expenses$16.7M$17M$18.7M$19.4M$6.62M
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$0.00$30K$20K$350K$620K
Depreciation and amortization$530K$660K$430K$290K$110K
Ebitda-$-12.03M-$-12.98M-$-15.13M-$-18.27M-$-6.35M
Operating income-$-12.79M-$-13.77M-$-15.73M-$-18.73M-$-6.46M
Total other income/expenses, net$240K$90K$150K-$-190K-$-620K
Income before tax-$-12.56M-$-13.67M-$-15.58M-$-18.92M-$-7.08M
Income tax expense$0.00$0.00$0.00$0.00$0.00
Net income-$-12.56M-$-13.67M-$-15.58M-$-18.92M-$-7.05M
Weighted average shares outstanding$7.38M$1.21M$230K$100K$10K
Weighted average diluted shares outstanding$7.38M$1.21M$230K$100K$10K
Balance sheet
20252024202320222021
Cash and short-term investments$3.76M$6.54M$2.43M$8.57M$7.32M
Net receivables$1.7M$860K$530K$240K$80K
Inventory$1.05M$610K$550K$410K$190K
Total current assets$6.77M$8.21M$3.89M$9.35M$7.67M
Property, plant and equipment, net$1.05M$1.15M$1.61M$1.67M$1.19M
Goodwill and intangible assets$2.89M$0.00$0.00$0.00$0.00
Long-term investments$0.00$0.00$0.00$0.00$0.00
Total non-current assets$3.99M$1.63M$2.46M$1.74M$1.6M
Total assets$10.8M$9.84M$6.34M$11.1M$9.27M
Accounts payable$840K$370K$430K$550K$480K
Short-term debt$140K$290K$1.43M$230K$13.7M
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$3.21M$1.87M$3.14M$2.53M$15.3M
Long-term debt$0.00$140K$430K$680K$910K
Deferred revenue, non-current$0.00$0.00-$-2M$0.00$0.00
Total non-current liabilities$2.51M$2M$2.43M$2.31M$14.6M
Capital lease obligations$140K$430K$680K$680K$1.11M
Total liabilities$5.72M$3.87M$5.57M$4.84M$29.8M
Common stock$10K$0.00$0.00$10K$0.00
Retained earnings-$-81.3M-$-68.75M-$-55.07M-$-39.49M-$-20.57M
Accumulated other comprehensive income (loss)$0.00$0.00-$-50K-$-100K-$-90K
Total equity$5.04M$5.97M$780K$6.25M-$-20.55M
Total investments$0.00$0.00$0.00$6.44M$4.4M
Total debt$140K$430K$1.86M$910K$14.6M
Net debt-$-3.62M-$-6.11M-$-570K-$-1.22M$11.7M
Cash flow statement
20252024202320222021
Net income-$-12.56M-$-13.67M-$-15.58M-$-18.92M-$-7.08M
Depreciation and amortization$530K$660K$430K$290K$110K
Stock-based compensation$1.69M$3.85M$4.14M$2.9M$380K
Change in working capital-$-430K-$-750K-$-1.17M$1.72M$450K
Accounts receivable-$-850K-$-390K-$-290K-$-150K-$-60K
Inventory-$-390K-$-50K-$-140K-$-230K-$-140K
Accounts payable$490K-$-60K-$-120K$70K$440K
Net cash provided by operating activities-$-10.74M-$-9.88M-$-12.18M-$-12.03M-$-4.29M
Investments in property, plant and equipment-$-270K-$-190K-$-360K-$-850K-$-100K
Acquisitions, net$0.00$0.00$0.00$0.00$0.00
Net cash used for investing activities-$-1.02M-$-190K$6.14M-$-2.88M-$-4.5M
Common stock issued$9.92M$6.61M$5.3M$14.1M$0.00
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$8.99M$14.1M$6.3M$14.1M$11.5M
Net change in cash-$-2.78M$4.11M$300K-$-790K$2.67M
Cash at end of period$3.76M$6.54M$2.43M$2.13M$2.92M
Operating cash flow-$-10.74M-$-9.88M-$-12.18M-$-12.03M-$-4.29M
Capital expenditure-$-270K-$-190K-$-360K-$-850K-$-100K
Free cash flow-$-11.02M-$-10.06M-$-12.54M-$-12.87M-$-4.39M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Tenon Medical, Inc.

        Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.

        CEO
        Steven Foster
        Employees
        26
        Beta
        1.36

        Explore

        Frequently asked questions

        What is the intrinsic value of Tenon Medical, Inc. (TNON)?

        InvestorsCraft does not currently publish an intrinsic value for TNON. How the IC value is calculated.

        Is TNON undervalued?

        InvestorsCraft does not publish an undervaluation signal for TNON at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.